TrialPloS one2018

Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.

Felien T M Busger Op Vollenbroek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.